OsteoSymbionics LLC FDA Inspection Record

FEI 3007223102 · Inspections, Form 483s, warning letters and import refusals

OsteoSymbionics LLC is an FDA-inspected facility (FEI 3007223102) located in Cleveland, OH, US. RegDataLab tracks 4 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Mar 29, 2017: Voluntary Action Indicated (VAI)
Inspections on record
4 (1 OAI, 2 VAI, 1 NAI)
Last OAI inspection
Nov 3, 2010
Warning letters
1 listed by FDA for this FEI, latest Nov 30, 2010

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 29, 2017Voluntary Action Indicated (VAI)Calibration procedures - content (21 CFR 820.72(b))
Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a))
Documentation (21 CFR 820.100(b))
Purchasing controls, Lack of or inadequate procedures (21 CFR 820.50)
Jun 25, 2013No Action Indicated (NAI)Design validation- Lack of or inadequate procedures (21 CFR 820.30(g))
Calibration, Inspection, etc. Procedures Lack of or Inadequ (21 CFR 820.72(a))
Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a))
Supplier oversight (21 CFR 820.50(a)(2))
and 1 more
Nov 3, 2011Voluntary Action Indicated (VAI)Document review, approval documentation (21 CFR 820.40(a))
Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a))
Documented evaluation (21 CFR 820.50(a)(1))
Design input - review and approval (21 CFR 820.30(c))
and 1 more
Nov 3, 2010Official Action Indicated (OAI)Design plans - Lack of or inadequate (21 CFR 820.30(b))
Design input - documentation (21 CFR 820.30(c))
Lack/Inad procedure-Monitoring/Control of Validated Proces (21 CFR 820.75(b))
Lack of or inadequate procedures (21 CFR 820.100(a))
and 6 more

FDA record score

2 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

4 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIMar 29, 20176 x 0.251.5
Inspection classified VAINov 3, 201110 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsNov 30, 201010 years or older, so it adds no points0
Inspection classified OAINov 3, 201010 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing OsteoSymbionics LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check OsteoSymbionics LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
OsteoSymbionics LLC
Location
Cleveland, OH (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.